Norway· NO-ID_3F5E281A-93FC-4937-B594-614F5D3F0286
Nadolol cipla
A nadolol product containing nadolol, registered in Norway by Cipla. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nadolol is registered in 6 of 19 countries.
Countries holding a registration under ATC C07AA12 (nadolol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Nadolol · ATC C07AA12
6 / 19 countries
- Canada
- Franceprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nadolol costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nadolol · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- FR France$0.84
The record
At a glance
FEST (Norway)- Active substance
- Nadolol
- Manufacturer
- Cipla
- Country
- Norway (NO)
- ATC code
- C07AA12
- ATC class
- Nadolol
- Defined daily dose
- 0.16 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_3F5E281A-93FC-4937-B594-614F5D3F0286
- no_varenummer269275100
- gtin369097868079
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
302 interactions on record for nadolol.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nadolol · interactions on record
302 records
- 31 severe
- 164 moderate
- 28 minor
- 79 info
Most severe, free to view
- DolasetronA04AA04severe
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nadolol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNadololZydus Pharmaceuticals USA Inc.
- CanadaAPO-NADOLOLAPOTEX INC
- United KingdomCorgard 40mg tabletsSanofi-Synthelabo Ltd
- FranceCORGARD 80 mg, comprimé sécableCHEPLAPHARM FRANCE
- Japanナドロール住友ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Corgard
- United Kingdom (Northern Ireland) · Nadolol Neon Healthcare
- Italy · Nadololo Cheplapharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c8523ff-2503-4eb3-8bc2-9631a6cafb25 GET /v1/drugs/3c8523ff-2503-4eb3-8bc2-9631a6cafb25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Nadolol",
"merkevare_id": "ID_3F5E281A-93FC-4937-B594-614F5D3F0286",
"name_form_strength": "Nadolol cipla tab 40 mg",
"prescription_group": "C"
}See everything about nadolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.